Page last updated: 2024-11-05

tolbutamide and Atrial Fibrillation

tolbutamide has been researched along with Atrial Fibrillation in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Specterman, MJ1
Aziz, Q1
Li, Y1
Anderson, NA1
Ojake, L1
Ng, KE1
Thomas, AM1
Finlay, MC1
Schilling, RJ1
Lambiase, PD1
Tinker, A1

Other Studies

1 other study available for tolbutamide and Atrial Fibrillation

ArticleYear
Hypoxia Promotes Atrial Tachyarrhythmias via Opening of ATP-Sensitive Potassium Channels.
    Circulation. Arrhythmia and electrophysiology, 2023, Volume: 16, Issue:9

    Topics: Adenosine Triphosphate; Animals; Atrial Fibrillation; Heart Atria; Humans; Hypoxia; KATP Channels; M

2023